Indirect suppression of CD4 T cell activation through LAG-3-mediated trans-endocytosis of MHC class II
Blockade of immune checkpoint receptors has shown outstanding efficacy for tumor immunotherapy. Promising treatment with anti-lymphocyte-activation gene-3 (LAG-3) has already been recognized as the next efficacious treatment, but there is still limited understanding of the mechanism of LAG-3-mediate...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | Artigo |
Lenguaje: | inglés |
Publicado: |
2024
|
Acceso en línea: | https://doi.org/10.1016/j.celrep.2024.114655 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|